Restorelle® Mesh Versus Native Tissue Repair for Prolapse

Inclusion Criteria: * Female at least 18 years of age * Subject has pelvic organ prolapse with leading edge at or beyond the hymen. At or beyond the hymen is defined as POP-Q scores of Ba ≥0 and C≥ -1/2 tvl or Bp ≥0 and C≥ -1/2 tvl * Subject reports a bothersome bulge they can see or feel per PFDI-20 question 3, response of 2 or higher (i.e. responses of "somewhat", "moderately" or "quite a bit") * Subject is willing to provide written informed consent * Subject is willing and able to comply with the follow-up regimen Exclusion Criteria: * Subject is pregnant or intends to become pregnant during the study * Subject has an active or chronic systemic infection including any gynecologic infection, untreated urinary tract infection (UTI), or tissue necrosis * Subject has a history of pelvic organ cancer (e.g. uterine, ovarian, bladder, or cervical) * Subject has had prior or is currently undergoing radiation, laser therapy, or chemotherapy in the pelvic area * Subject has taken systemic steroids (within the last month), or immunosuppressive or immunomodulatory treatment (within the last 3 months) * Subject has a systemic connective tissue disease (e.g. scleroderma, systemic lupus erythematosus (SLE), Marfan syndrome, Ehlers Danlos, collagenosis, polymyositis or polymyalgia rheumatica) * Subject has chronic systemic pain that includes the pelvic area or chronic focal pain that involves the pelvis * Subject has uncontrolled diabetes mellitus (DM) * Subject has a known neurologic or medical condition affecting bladder function (e.g. multiple sclerosis, spinal cord injury, or stroke with residual neurologic deficit) * Subject is seeking obliterative vaginal surgery as treatment for pelvic organ prolapse (colpocleisis) * Subject is not able to conform to the modified dorsal lithotomy position * Subject is currently participating in or plans to participate in another device or drug study during this study * Subject has a known sensitivity to polypropylene * Subject has had previous prolapse repair with mesh in the target compartment(s) * Subject is planning to undergo a concomitant prolapse repair in a non-target compartment with anything other than native tissue repair